Segui
Beatrice Belmonte
Beatrice Belmonte
Laboratorio di Immunologia dei tumori
Email verificata su unipa.it
Titolo
Citata da
Citata da
Anno
WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer
L Castagnoli, V Cancila, SL Cordoba-Romero, S Faraci, G Talarico, ...
Oncogene 38 (21), 4047-4060, 2019
1172019
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection
S Petta, C Camma, VD Marco, FS Macaluso, M Maida, G Pizzolanti, ...
Liver International 31 (4), 507-515, 2011
1092011
Pathogenic role of complement in antiphospholipid syndrome and therapeutic implications
F Tedesco, MO Borghi, M Gerosa, CB Chighizola, P Macor, PA Lonati, ...
Frontiers in Immunology 9, 1388, 2018
412018
Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate CancerMast Cells Foster Tumor Immune Suppression
E Jachetti, V Cancila, A Rigoni, L Bongiovanni, B Cappetti, B Belmonte, ...
Cancer immunology research 6 (5), 552-565, 2018
382018
Complement protein C1q binds to hyaluronic acid in the malignant pleural mesothelioma microenvironment and promotes tumor growth
C Agostinis, R Vidergar, B Belmonte, A Mangogna, L Amadio, P Geri, ...
Frontiers in immunology 8, 1559, 2017
322017
New landscapes and horizons in hepatocellular carcinoma therapy
M Cervello, MR Emma, G Augello, A Cusimano, L Giannitrapani, M Soresi, ...
Aging (Albany NY) 12 (3), 3053, 2020
312020
Is the complement protein C1q a pro-or anti-tumorigenic factor? Bioinformatics analysis involving human carcinomas
A Mangogna, C Agostinis, D Bonazza, B Belmonte, P Zacchi, G Zito, ...
Frontiers in immunology 10, 865, 2019
292019
Prognostic implications of the complement protein C1q in gliomas
A Mangogna, B Belmonte, C Agostinis, P Zacchi, DG Iacopino, ...
Frontiers in immunology, 2366, 2019
272019
Evaluation of thermoresponsive properties and biocompatibility of polybenzofulvene aggregates for leuprolide delivery
M Licciardi, G Amato, A Cappelli, M Paolino, G Giuliani, B Belmonte, ...
International journal of pharmaceutics 438 (1-2), 279-286, 2012
272012
Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma
G Augello, MR Emma, A Cusimano, A Azzolina, S Mongiov, R Puleio, ...
International journal of cancer 144 (10), 2613-2624, 2019
262019
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis
F Colombo, P Durigutto, L De Maso, S Biffi, B Belmonte, C Tripodo, ...
Journal of Autoimmunity 103, 102288, 2019
202019
Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients
E Ferretti, S Hohaus, A Di Napoli, B Belmonte, A Cuccaro, E Cupelli, ...
Oncotarget 8 (49), 85263, 2017
192017
Pathological significance and prognostic value of surfactant protein D in cancer
A Mangogna, B Belmonte, C Agostinis, G Ricci, A Gulino, I Ferrara, ...
Frontiers in Immunology 9, 1748, 2018
182018
The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer
L Forte, F Turdo, C Ghirelli, P Aiello, P Casalini, MV Iorio, E D’Ippolito, ...
BMC cancer 18 (1), 1-11, 2018
152018
Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast CancerImplication of Gut Microbes in Response to Trastuzumab Therapy
M Di Modica, G Gargari, V Regondi, A Bonizzi, S Arioli, B Belmonte, ...
Cancer Research 81 (8), 2195-2206, 2021
142021
Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cells
MC Anania, E Cetti, D Lecis, K Todoerti, A Gulino, G Mauro, T Di Marco, ...
Cancer letters 410, 201-211, 2017
142017
Biocompatibility and biodegradability of electrospun PHEA-PLA scaffolds: our preliminary experience in a murine animal model
AI Lo Monte, M Licciardi, M Bellavia, G Damiano, VD Palumbo, ...
Digest Journal of Nanomaterials and Biostructures 7 (2), 841-851, 2012
142012
CD10 and HHF35 actin in the differential diagnosis between Collagenous spherulosis and adenoid-cystic carcinoma of the breast
D Cabibi, AG Giannone, B Belmonte, F Aragona, F Aragona
Pathology-Research and Practice 208 (7), 405-409, 2012
122012
Cross-talk between myeloid-derived suppressor cells and mast cells mediates tumor-specific immunosuppression in prostate cancer. Cancer Immunol. Res. 2018; 6: 552–565. doi: 10…
E Jachetti, V Cancila, A Rigoni, L Bongiovanni, B Cappetti, B Belmonte, ...
CIR-17-0385, 0
10
Hyaluronic acid present in the tumor microenvironment can negate the pro-apototic effect of a recombinant fragment of human surfactant protein D on breast cancer cells
V Murugaiah, C Agostinis, PM Varghese, B Belmonte, S Vieni, FA Alaql, ...
Frontiers in Immunology 11, 1171, 2020
92020
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20